BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,357,545 | +3.5% | 412,628 | 0.0% | 0.22% | -27.5% |
Q1 2023 | $1,312,157 | -76.7% | 412,628 | -49.2% | 0.30% | -78.0% |
Q4 2022 | $5,623,385 | +92.1% | 812,628 | +75.7% | 1.36% | +132.8% |
Q3 2022 | $2,928,000 | +292700.0% | 462,628 | +151085.6% | 0.58% | – |
Q1 2022 | $1,000 | -50.0% | 306 | +6.6% | 0.00% | – |
Q4 2021 | $2,000 | -99.9% | 287 | -99.7% | 0.00% | -100.0% |
Q1 2021 | $3,211,000 | -30.3% | 106,481 | 0.0% | 0.11% | -47.1% |
Q4 2020 | $4,607,000 | +112.0% | 106,481 | +164.3% | 0.20% | +29.9% |
Q3 2020 | $2,173,000 | -74.5% | 40,281 | -71.2% | 0.16% | -76.9% |
Q2 2020 | $8,538,000 | +142.8% | 139,874 | +82.8% | 0.68% | +157.2% |
Q1 2020 | $3,516,000 | – | 76,498 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |